Skip to content

An effectiveness confirmation test of test food consumption

An effectiveness confirmation test of test food consumption - An effectiveness confirmation test of test food consumption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037529
Enrollment
100
Registered
2020-07-29
Start date
2019-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake two tablets of test food which contain pterostilbene for four weeks Intake two tablets of test food which contain pterostilbene for four weeks

Sponsors

Kewpie Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)Males aged 45-64 years at a time of obtaining informed consent. 2)Subjects who show understanding of the clinical study procedures and agreement with participating this study by written informed consent.

Exclusion criteria

Exclusion criteria: 1)Subjects who are currently receiving medication. 2)Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). 3)Subjects who have excessive alcohol intake. 4)Subjects who constantly use oral medicines, Food for Specified Health Uses (FOSHU), functional foods, supplements and/or healthy foods having a possibility of affecting test results. 5)Subjects who have extremely irregular dietary habits, have midnight work or irregular shift work. 6)Subjects who have allergy to medicines or foods (especially gelatin). 7)Subjects who are participating the other clinical test, were participating it within the past 4 weeks, or are going to participate it. 8)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 9)Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 10)Subjects who is going to be collected over 1200mL blood and/or blood components which is collected whithin the last 12 month and at this study 11)Subjects judged as unsuitable for the study by the principal or attending investigator.

Design outcomes

Primary

MeasureTime frame
Level of blood miRNA

Secondary

MeasureTime frame
Level of blood total protein Level of blood albumin Level of blood AST Level of blood ALT Level of blood LDH Level of blood total bilirubin Level of blood ALP Level of blood gamma-GTP Level of blood CPK Level of blood BUN Level of blood CRE Level of blood UA Level of blood Na Level of blood Cl Level of blood K Level of blood Ca Level of blood total cholesterol Level of blood LDL-cholesterol Level of blood HDL-cholesterol Level of blood triglyceride Level of blood glucose

Countries

Japan

Contacts

Public ContactDaisuke Kuriki

Kewpie Corporation Evaluation & Analysis Sciences Department Institute of Technology Solutions, R&D Division

daisuke_kuriki@kewpie.co.jp03-5384-7759

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026